Ibrutinib-associated cutaneous mucormycosis due to an Apophysomyces species: report of a case and re...
Ibrutinib-associated cutaneous mucormycosis due to an Apophysomyces species: report of a case and review of the literature
About this item
Full title
Author / Creator
Publisher
London, England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
London, England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
The use of ibrutinib, a Bruton tyrosine kinase inhibitor, has been associated with invasive fungal infections (IFIs). We describe a case of Apophysomyces infection associated with long-term use of ibrutinib for the treatment of chronic lymphocytic leukemia as well as perform a literature review of Mucormycosis infections in patients on ibrutinib. O...
Alternative Titles
Full title
Ibrutinib-associated cutaneous mucormycosis due to an Apophysomyces species: report of a case and review of the literature
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10966995
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10966995
Other Identifiers
ISSN
2049-9361
E-ISSN
2049-937X
DOI
10.1177/20499361241241199
